Literature DB >> 29043468

Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments.

Costanza Papagno1,2, Luigi Trojano3,4.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by motor symptoms such as rigidity, rest tremor, and bradykinesia. However, a growing body of evidence demonstrated that PD encompasses several non-motor disturbances as well, such as cognitive impairment. Cognitive defects can be present since early stages of the disease but tend to dominate the clinical picture as the disease progresses. Around 40% of patients with PD present with cognitive impairments in several cognitive domains including attention, working memory and executive functions, language, visuospatial skills, and episodic memory; in later stages of the disease, cognitive defects and associated behavioral disorders concur to determine clinically relevant PD-associated dementia. Part of these defects is ascribed to a dopamine-dependent dysfunction of fronto-striatal pathways, but there is a considerable heterogeneity in the cognitive impairments as well as a suggestion of the role of other neurotransmitter systems, such as the cholinergic one, mainly responsible for Parkinson-dementia syndrome. In this paper, we review recent literature with particular attention to the last 5 years on the main cognitive deficits described in PD patients as well as on the hypothesized neuro-functional substrate of such impairments. Finally, we provide some suggestions on how to test cognitive functions in PD appropriately.

Entities:  

Keywords:  Cognitive impairment; Dementia; Executive functions; Fronto-striatal pathways; Parkinson’s disease

Mesh:

Year:  2017        PMID: 29043468     DOI: 10.1007/s10072-017-3154-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  74 in total

1.  Closing-in in Parkinson's disease individuals with dementia: An experimental study.

Authors:  Natascia De Lucia; Dario Grossi; Alfonso Mauro; Luigi Trojano
Journal:  J Clin Exp Neuropsychol       Date:  2015       Impact factor: 2.475

2.  Action verbal fluency in Parkinson's patients.

Authors:  Inês Tello Rodrigues; Joaquim J Ferreira; Miguel Coelho; Mario M Rosa; Alexandre Castro-Caldas
Journal:  Arq Neuropsiquiatr       Date:  2015-06       Impact factor: 1.420

3.  Lexical-retrieval and semantic memory in Parkinson's disease: The question of noun and verb dissociation.

Authors:  Henrique Salmazo-Silva; Maria Alice de Mattos Pimenta Parente; Maria Sheila Rocha; Roberta Roque Baradel; André M Cravo; João Ricardo Sato; Fabio Godinho; Maria Teresa Carthery-Goulart
Journal:  Brain Lang       Date:  2016-11-30       Impact factor: 2.381

4.  Associative reinstatement memory measures hippocampal function in Parkinson's Disease.

Authors:  Melanie Cohn; Irene Giannoylis; Maya De Belder; Jean A Saint-Cyr; Mary Pat McAndrews
Journal:  Neuropsychologia       Date:  2016-04-29       Impact factor: 3.139

5.  Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study.

Authors:  Gabriella Santangelo; Carmine Vitale; Marina Picillo; Marcello Moccia; Sofia Cuoco; Katia Longo; Domenica Pezzella; Assunta di Grazia; Roberto Erro; Maria Teresa Pellecchia; Marianna Amboni; Luigi Trojano; Paolo Barone
Journal:  Parkinsonism Relat Disord       Date:  2015-08-21       Impact factor: 4.891

6.  Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS).

Authors:  Gabriella Santangelo; Paolo Barone; Giovanni Abbruzzese; Luigi Ferini-Strambi; Angelo Antonini
Journal:  Neurol Sci       Date:  2013-09-25       Impact factor: 3.307

7.  The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

Authors:  Caroline H Williams-Gray; Sarah L Mason; Jonathan R Evans; Thomas Foltynie; Carol Brayne; Trevor W Robbins; Roger A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-18       Impact factor: 10.154

8.  Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.

Authors:  Sophie Fengler; Josef Kessler; Lars Timmermann; Alexandra Zapf; Saskia Elben; Lars Wojtecki; Oliver Tucha; Elke Kalbe
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

9.  Normal aging and Parkinson's disease are associated with the functional decline of distinct frontal-striatal circuits.

Authors:  Aleksandra Gruszka; Adam Hampshire; Roger A Barker; Adrian M Owen
Journal:  Cortex       Date:  2017-06-03       Impact factor: 4.027

Review 10.  Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis.

Authors:  Angie A Kehagia; Roger A Barker; Trevor W Robbins
Journal:  Neurodegener Dis       Date:  2012-10-03       Impact factor: 2.977

View more
  25 in total

1.  Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Authors:  Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton
Journal:  J Clin Exp Neuropsychol       Date:  2019-06-10       Impact factor: 2.475

2.  Improving motor performance in Parkinson's disease: a preliminary study on the promising use of the computer assisted virtual reality environment (CAREN).

Authors:  Rocco Salvatore Calabrò; Antonino Naro; Vincenzo Cimino; Antonio Buda; Giuseppe Paladina; Giuseppe Di Lorenzo; Alfredo Manuli; Demetrio Milardi; Placido Bramanti; Alessia Bramanti
Journal:  Neurol Sci       Date:  2019-12-19       Impact factor: 3.307

Review 3.  Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.

Authors:  Luigi Trojano; Costanza Papagno
Journal:  Neurol Sci       Date:  2017-10-16       Impact factor: 3.307

Review 4.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

5.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

6.  Non-motor symptoms of Parkinson's disease: dopaminergic basis or not?

Authors:  Chanwoo Kim
Journal:  Neurol Sci       Date:  2019-06-17       Impact factor: 3.307

7.  FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation.

Authors:  Shu Yao; Longjun Li; Xin Sun; Jun Hua; Keqi Zhang; Li Hao; Lixin Liu; Dongyan Shi; Hong Zhou
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-08       Impact factor: 4.147

8.  White matter alterations in early Parkinson's disease: role of motor symptom lateralization.

Authors:  Laura Pelizzari; Sonia Di Tella; Maria M Laganà; Niels Bergsland; Federica Rossetto; Raffaello Nemni; Francesca Baglio
Journal:  Neurol Sci       Date:  2019-10-24       Impact factor: 3.307

9.  Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.

Authors:  Jacob D Jones; Carmen Uribe; Joseph Bunch; Kelsey R Thomas
Journal:  J Neurol       Date:  2020-08-17       Impact factor: 4.849

10.  Cognitive processes that indirectly affect olfactory dysfunction in Parkinson's disease.

Authors:  Attakias T Mertens; Jonathan B Santo; Katerina Markopoulou; Bruce A Chase
Journal:  Clin Park Relat Disord       Date:  2019-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.